Selective inhibition of tumor oncogenes by disruption of super-enhancers

Cell

Volumn 153, Issue 2, 2013, Pages 320-334

  Lovén, Jakob ^a   Hoke, Heather A ^a,b   Lin, Charles Y ^a,b,d   Lau, Ashley ^a,b   Orlando, David A ^a   Vakoc, Christopher R ^c   Bradner, James E ^d,e   Lee, Tong Ihn ^a   Young, Richard A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTIONAL COACTIVATOR BRD4; UNCLASSIFIED DRUG;

ARTICLE; ENHANCER REGION; GENE EXPRESSION; GENE INACTIVATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; ONCOGENE MYC; PRIORITY JOURNAL; TRANSCRIPTION ELONGATION; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 84876222028     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.03.036     Document Type: Article

References (86)

1. S.B. Baylin, and P.A. Jones A decade of exploring the cancer epigenome - biological and translational implications Nat. Rev. Cancer 11 2011 726 734
2. P.L. Bergsagel, W.M. Kuehl, F. Zhan, J. Sawyer, B. Barlogie, and J. Shaughnessy Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma Blood 106 2005 296 303
3. R. Beroukhim, C.H. Mermel, D. Porter, G. Wei, S. Raychaudhuri, J. Donovan, J. Barretina, J.S. Boehm, J. Dobson, and M. Urashima The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
4. T. Borggrefe, and X. Yue Interactions between subunits of the Mediator complex with gene-specific transcription factors Semin. Cell Dev. Biol. 22 2011 759 768
5. M. Carey The enhanceosome and transcriptional synergy Cell 92 1998 5 8
6. M. Carey, J. Leatherwood, and M. Ptashne A potent GAL4 derivative activates transcription at a distance in vitro Science 247 1990 710 712
7. D.R. Carrasco, K. Sukhdeo, M. Protopopova, R. Sinha, M. Enos, D.E. Carrasco, M. Zheng, M. Mani, J. Henderson, and G.S. Pinkus The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis Cancer Cell 11 2007 349 360
8. M.S. Carro, W.K. Lim, M.J. Alvarez, R.J. Bollo, X. Zhao, E.Y. Snyder, E.P. Sulman, S.L. Anne, F. Doetsch, and H. Colman The transcriptional network for mesenchymal transformation of brain tumours Nature 463 2010 318 325
9. I. Chepelev, G. Wei, D. Wangsa, Q. Tang, and K. Zhao Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization Cell Res. 22 2012 490 503
10. H.W. Cheung, G.S. Cowley, B.A. Weir, J.S. Boehm, S. Rusin, J.A. Scott, A. East, L.D. Ali, P.H. Lizotte, and T.C. Wong Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer Proc. Natl. Acad. Sci. USA 108 2011 12372 12377
11. L. Chin, A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, and H. Zhou Essential role for oncogenic Ras in tumour maintenance Nature 400 1999 468 472
12. W.J. Chng, G.F. Huang, T.H. Chung, S.B. Ng, N. Gonzalez-Paz, T. Troska-Price, G. Mulligan, M. Chesi, P.L. Bergsagel, and R. Fonseca Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma Leukemia 25 2011 1026 1035
13. J.O. Claudio, E. Masih-Khan, H. Tang, J. Gonçalves, M. Voralia, Z.H. Li, V. Nadeem, E. Cukerman, O. Francisco-Pabalan, and C.C. Liew A molecular compendium of genes expressed in multiple myeloma Blood 100 2002 2175 2186
14. P.A. Cole Chemical probes for histone-modifying enzymes Nat. Chem. Biol. 4 2008 590 597
15. R.C. Conaway, and J.W. Conaway Function and regulation of the Mediator complex Curr. Opin. Genet. Dev. 21 2011 225 230
16. M.P. Creyghton, A.W. Cheng, G.G. Welstead, T. Kooistra, B.W. Carey, E.J. Steine, J. Hanna, M.A. Lodato, G.M. Frampton, and P.A. Sharp Histone H3K27ac separates active from poised enhancers and predicts developmental state Proc. Natl. Acad. Sci. USA 107 2010 21931 21936
17. M.A. Dawson, and T. Kouzarides Cancer epigenetics: from mechanism to therapy Cell 150 2012 12 27
18. M.A. Dawson, R.K. Prinjha, A. Dittmann, G. Giotopoulos, M. Bantscheff, W.I. Chan, S.C. Robson, C.W. Chung, C. Hopf, and M.M. Savitski Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia Nature 478 2011 529 533
19. J.E. Delmore, G.C. Issa, M.E. Lemieux, P.B. Rahl, J. Shi, H.M. Jacobs, E. Kastritis, T. Gilpatrick, R.M. Paranal, and J. Qi BET bromodomain inhibition as a therapeutic strategy to target c-Myc Cell 146 2011 904 917
20. A. Dey, F. Chitsaz, A. Abbasi, T. Misteli, and K. Ozato The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis Proc. Natl. Acad. Sci. USA 100 2003 8758 8763
21. A. Dib, A. Gabrea, O.K. Glebov, P.L. Bergsagel, and W.M. Kuehl Characterization of MYC translocations in multiple myeloma cell lines J. Natl. Cancer Inst. Monogr. 39 2008 25 31
22. J.R. Dixon, S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J.S. Liu, and B. Ren Topological domains in mammalian genomes identified by analysis of chromatin interactions Nature 485 2012 376 380
23. S.J. Elsässer, C.D. Allis, and P.W. Lewis Cancer. New epigenetic drivers of cancers Science 331 2011 1145 1146
24. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
25. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat. Rev. Cancer 4 2004 143 153
26. D.W. Felsher, and J.M. Bishop Reversible tumorigenesis by MYC in hematopoietic lineages Mol. Cell 4 1999 199 207
27. P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W.B. Smith, O. Fedorov, E.M. Morse, T. Keates, T.T. Hickman, and I. Felletar Selective inhibition of BET bromodomains Nature 468 2010 1067 1073
28. L.A. Garraway, and W.R. Sellers Lineage dependency and lineage-survival oncogenes in human cancer Nat. Rev. Cancer 6 2006 593 602
29. L.A. Garraway, H.R. Widlund, M.A. Rubin, G. Getz, A.J. Berger, S. Ramaswamy, R. Beroukhim, D.A. Milner, S.R. Granter, and J. Du Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma Nature 436 2005 117 122
30. E.J. Geutjes, P.K. Bajpe, and R. Bernards Targeting the epigenome for treatment of cancer Oncogene 31 2012 3827 3844
31. K. Giese, C. Kingsley, J.R. Kirshner, and R. Grosschedl Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions Genes Dev. 9 1995 995 1008
32. E. Giniger, and M. Ptashne Cooperative DNA binding of the yeast transcriptional activator GAL4 Proc. Natl. Acad. Sci. USA 85 1988 382 386
33. A. Göndör, and R. Ohlsson Chromosome crosstalk in three dimensions Nature 461 2009 212 217
34. D.W. Griggs, and M. Johnston Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression Proc. Natl. Acad. Sci. USA 88 1991 8597 8601
35. N.D. Heintzman, G.C. Hon, R.D. Hawkins, P. Kheradpour, A. Stark, L.F. Harp, Z. Ye, L.K. Lee, R.K. Stuart, and C.W. Ching Histone modifications at human enhancers reflect global cell-type-specific gene expression Nature 459 2009 108 112
36. T. Holien, T.K. Våtsveen, H. Hella, A. Waage, and A. Sundan Addiction to c-MYC in multiple myeloma Blood 120 2012 2450 2453
37. J.P. Issa, and H.M. Kantarjian Targeting DNA methylation Clin. Cancer Res. 15 2009 3938 3946
38. M. Jain, C. Arvanitis, K. Chu, W. Dewey, E. Leonhardt, M. Trinh, C.D. Sundberg, J.M. Bishop, and D.W. Felsher Sustained loss of a neoplastic phenotype by brief inactivation of MYC Science 297 2002 102 104
39. M.K. Jang, K. Mochizuki, M. Zhou, H.S. Jeong, J.N. Brady, and K. Ozato The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription Mol. Cell 19 2005 523 534
40. Y.W. Jiang, P. Veschambre, H. Erdjument-Bromage, P. Tempst, J.W. Conaway, R.C. Conaway, and R.D. Kornberg Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways Proc. Natl. Acad. Sci. USA 95 1998 8538 8543
41. M.H. Kagey, J.J. Newman, S. Bilodeau, Y. Zhan, D.A. Orlando, N.L. van Berkum, C.C. Ebmeier, J. Goossens, P.B. Rahl, and S.S. Levine Mediator and cohesin connect gene expression and chromatin architecture Nature 467 2010 430 435
42. T.K. Kim, and T. Maniatis The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome Mol. Cell 1 1997 119 129
43. R.D. Kornberg Mediator and the mechanism of transcriptional activation Trends Biochem. Sci. 30 2005 235 239
44. B.J. Krueger, K. Varzavand, J.J. Cooper, and D.H. Price The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK PLoS ONE 5 2010 e12335
45. B. Langmead, C. Trapnell, M. Pop, and S.L. Salzberg Ultrafast and memory-efficient alignment of short DNA sequences to the human genome Genome Biol. 10 2009 R25
46. K.M. Lelli, M. Slattery, and R.S. Mann Disentangling the many layers of eukaryotic transcriptional regulation Annu. Rev. Genet. 46 2012 43 68
47. G. LeRoy, B. Rickards, and S.J. Flint The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription Mol. Cell 30 2008 51 60
48. C.Y. Lin, J. Lovén, P.B. Rahl, R.M. Paranal, C.B. Burge, J.E. Bradner, T.I. Lee, and R.A. Young Transcriptional amplification in tumor cells with elevated c-Myc Cell 151 2012 56 67
49. V. Maldonado, and J. Melendez-Zajgla Role of Bcl-3 in solid tumors Mol. Cancer 10 2011 152
50. S. Malik, and R.G. Roeder The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation Nat. Rev. Genet. 11 2010 761 772
51. P.A. Marks, and W.S. Xu Histone deacetylase inhibitors: Potential in cancer therapy J. Cell. Biochem. 107 2009 600 608
52. J.A. Mertz, A.R. Conery, B.M. Bryant, P. Sandy, S. Balasubramanian, D.A. Mele, L. Bergeron, and R.J. Sims 3rd Targeting MYC dependence in cancer by inhibiting BET bromodomains Proc. Natl. Acad. Sci. USA 108 2011 16669 16674
53. E.A. Musgrove, C.E. Caldon, J. Barraclough, A. Stone, and R.L. Sutherland Cyclin D as a therapeutic target in cancer Nat. Rev. Cancer 11 2011 558 572
54. E. Nicodeme, K.L. Jeffrey, U. Schaefer, S. Beinke, S. Dewell, C.W. Chung, R. Chandwani, I. Marazzi, P. Wilson, and H. Coste Suppression of inflammation by a synthetic histone mimic Nature 468 2010 1119 1123
55. C.T. Ong, and V.G. Corces Enhancer function: new insights into the regulation of tissue-specific gene expression Nat. Rev. Genet. 12 2011 283 293
56. C.J. Ott, N. Kopp, L. Bird, R.M. Paranal, J. Qi, T. Bowman, S.J. Rodig, A.L. Kung, J.E. Bradner, and D.M. Weinstock BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia Blood 120 2012 2843 2852
57. N. Pedersen, S. Mortensen, S.B. Sørensen, M.W. Pedersen, K. Rieneck, L.F. Bovin, and H.S. Poulsen Transcriptional gene expression profiling of small cell lung cancer cells Cancer Res. 63 2003 1943 1953
58. J. Perk, A. Iavarone, and R. Benezra Id family of helix-loop-helix proteins in cancer Nat. Rev. Cancer 5 2005 603 614
59. A. Rada-Iglesias, R. Bajpai, T. Swigut, S.A. Brugmann, R.A. Flynn, and J. Wysocka A unique chromatin signature uncovers early developmental enhancers in humans Nature 470 2011 279 283
60. S. Rahman, M.E. Sowa, M. Ottinger, J.A. Smith, Y. Shi, J.W. Harper, and P.M. Howley The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3 Mol. Cell. Biol. 31 2011 2641 2652
61. A.M. Reimold, N.N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E.M. Gravallese, D. Friend, M.J. Grusby, F. Alt, and L.H. Glimcher Plasma cell differentiation requires the transcription factor XBP-1 Nature 412 2001 300 307
62. A.L. Shaffer, N.C. Emre, L. Lamy, V.N. Ngo, G. Wright, W. Xiao, J. Powell, S. Dave, X. Yu, and H. Zhao IRF4 addiction in multiple myeloma Nature 454 2008 226 231
63. N. Shah, B. Pang, K.G. Yeoh, S. Thorn, C.S. Chen, M.B. Lilly, and M. Salto-Tellez Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal Eur. J. Cancer 44 2008 2144 2151
64. M. Shapiro-Shelef, K.I. Lin, L.J. McHeyzer-Williams, J. Liao, M.G. McHeyzer-Williams, and K. Calame Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells Immunity 19 2003 607 620
65. Y. Shou, M.L. Martelli, A. Gabrea, Y. Qi, L.A. Brents, A. Roschke, G. Dewald, I.R. Kirsch, P.L. Bergsagel, and W.M. Kuehl Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma Proc. Natl. Acad. Sci. USA 97 2000 228 233
66. F. Spitz, and E.E. Furlong Transcription factors: from enhancer binding to developmental control Nat. Rev. Genet. 13 2012 613 626
67. D.J. Taatjes The human Mediator complex: a versatile, genome-wide regulator of transcription Trends Biochem. Sci. 35 2010 315 322
68. D. Thanos, and T. Maniatis Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome Cell 83 1995 1091 1100
69. C.A. Turner Jr., D.H. Mack, and M.M. Davis Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells Cell 77 1994 297 306
70. I.B. Weinstein Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 297 2002 63 64
71. W.A. Whyte, D.A. Orlando, D. Hnisz, B.J. Abraham, C.Y. Lin, M.H. Kagey, P.B. Rahl, T.I. Lee, and R.A. Young Master transcription factors and mediator establish super-enhancers at key cell identity genes Cell 153 2013 307 319 this issue
72. S.Y. Wu, and C.M. Chiang The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation J. Biol. Chem. 282 2007 13141 13145
73. S.Y. Wu, T. Zhou, and C.M. Chiang Human mediator enhances activator-facilitated recruitment of RNA polymerase II and promoter recognition by TATA-binding protein (TBP) independently of TBP-associated factors Mol. Cell. Biol. 23 2003 6229 6242
74. S.Y. Wu, A.Y. Lee, H.T. Lai, H. Zhang, and C.M. Chiang Phospho switch triggers brd4 chromatin binding and activator recruitment for gene-specific targeting Mol. Cell 49 2013 843 857
75. Z. Yang, J.H. Yik, R. Chen, N. He, M.K. Jang, K. Ozato, and Q. Zhou Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4 Mol. Cell 19 2005 535 545
76. J.S. You, and P.A. Jones Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22 2012 9 20
77. Y. Zhang, T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, B.E. Bernstein, C. Nusbaum, R.M. Myers, M. Brown, W. Li, and X.S. Liu Model-based analysis of ChIP-Seq (MACS) Genome Biol. 9 2008 R137
78. W. Zhang, C. Prakash, C. Sum, Y. Gong, Y. Li, J.J. Kwok, N. Thiessen, S. Pettersson, S.J. Jones, and S. Knapp Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells J. Biol. Chem. 287 2012 43137 43155
79. J. Zuber, J. Shi, E. Wang, A.R. Rappaport, H. Herrmann, E.A. Sison, D. Magoon, J. Qi, K. Blatt, and M. Wunderlich RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature 478 2011 524 528
80. M.N. Cabili, C. Trapnell, L. Goff, M. Koziol, B. Tazon-Vega, A. Regev, and J.L. Rinn Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses Genes Dev. 25 2011 1915 1927
81. P.A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman, and M.R. Stratton A census of human cancer genes Nat. Rev. Cancer 4 2004 177 183
82. M.G. Guenther, S.S. Levine, L.A. Boyer, R. Jaenisch, and R.A. Young A chromatin landmark and transcription initiation at most promoters in human cells Cell 130 2007 77 88
83. J. Lovén, D.A. Orlando, A.A. Sigova, C.Y. Lin, P.B. Rahl, C.B. Burge, D.L. Levens, T.I. Lee, and R.A. Young Revisiting global gene expression analysis Cell 151 2012 476 482
84. M.N. Patel, M.D. Halling-Brown, J.E. Tym, P. Workman, and B. Al-Lazikani Objective assessment of cancer genes for drug discovery Nat. Rev. Drug Discov. 12 2013 35 50
85. K.D. Pruitt, T. Tatusova, and D.R. Maglott NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins Nucleic Acids Res. 35 Database issue 2007 D61 D65
86. D. Ramsköld, E.T. Wang, C.B. Burge, and R. Sandberg An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data PLoS Comput. Biol. 5 2009 e1000598